Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges

Autores
Gutman, Graciela Elena; Lavarello, Pablo Jose
Año de publicación
2014
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that does not facilitate the resolution of the particular risks and uncertainties – be they technological, regulatory, or commercial – associated with these products. This paper examines the strategies of selected firms, using case studies. It postulates that firm organisation in economic groups, and the articulation in public/private networks enables local firms to successfully surmount the obstacles faced by innovative biotechnology firms in peripheral countries, which leads in turn to the achievement of technological and financial advantages.
Fil: Gutman, Graciela Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; Argentina
Fil: Lavarello, Pablo Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; Argentina
Materia
Biotechnology
Pharmaceutics Industry
Firm Strategies
Developing Countries
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/15612

id CONICETDig_e0e66aeb288cdd40058ebc3214fd321b
oai_identifier_str oai:ri.conicet.gov.ar:11336/15612
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Biopharmaceuticals and firm organization in Argentina. Opportunities and challengesGutman, Graciela ElenaLavarello, Pablo JoseBiotechnologyPharmaceutics IndustryFirm StrategiesDeveloping Countrieshttps://purl.org/becyt/ford/5.2https://purl.org/becyt/ford/5In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that does not facilitate the resolution of the particular risks and uncertainties – be they technological, regulatory, or commercial – associated with these products. This paper examines the strategies of selected firms, using case studies. It postulates that firm organisation in economic groups, and the articulation in public/private networks enables local firms to successfully surmount the obstacles faced by innovative biotechnology firms in peripheral countries, which leads in turn to the achievement of technological and financial advantages.Fil: Gutman, Graciela Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; ArgentinaFil: Lavarello, Pablo Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; ArgentinaInderscience Enterprises Ltd2014-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/zipapplication/pdfhttp://hdl.handle.net/11336/15612Gutman, Graciela Elena; Lavarello, Pablo Jose; Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges; Inderscience Enterprises Ltd; International Journal Technology and Globalization; 7; 3; 3-2014; 159-1781476-5667enginfo:eu-repo/semantics/altIdentifier/url/http://www.inderscienceonline.com/doi/abs/10.1504/IJTG.2014.064740info:eu-repo/semantics/altIdentifier/doi/10.1504/IJTG.2014.064740info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T12:05:52Zoai:ri.conicet.gov.ar:11336/15612instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 12:05:52.764CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges
title Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges
spellingShingle Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges
Gutman, Graciela Elena
Biotechnology
Pharmaceutics Industry
Firm Strategies
Developing Countries
title_short Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges
title_full Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges
title_fullStr Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges
title_full_unstemmed Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges
title_sort Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges
dc.creator.none.fl_str_mv Gutman, Graciela Elena
Lavarello, Pablo Jose
author Gutman, Graciela Elena
author_facet Gutman, Graciela Elena
Lavarello, Pablo Jose
author_role author
author2 Lavarello, Pablo Jose
author2_role author
dc.subject.none.fl_str_mv Biotechnology
Pharmaceutics Industry
Firm Strategies
Developing Countries
topic Biotechnology
Pharmaceutics Industry
Firm Strategies
Developing Countries
purl_subject.fl_str_mv https://purl.org/becyt/ford/5.2
https://purl.org/becyt/ford/5
dc.description.none.fl_txt_mv In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that does not facilitate the resolution of the particular risks and uncertainties – be they technological, regulatory, or commercial – associated with these products. This paper examines the strategies of selected firms, using case studies. It postulates that firm organisation in economic groups, and the articulation in public/private networks enables local firms to successfully surmount the obstacles faced by innovative biotechnology firms in peripheral countries, which leads in turn to the achievement of technological and financial advantages.
Fil: Gutman, Graciela Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; Argentina
Fil: Lavarello, Pablo Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; Argentina
description In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that does not facilitate the resolution of the particular risks and uncertainties – be they technological, regulatory, or commercial – associated with these products. This paper examines the strategies of selected firms, using case studies. It postulates that firm organisation in economic groups, and the articulation in public/private networks enables local firms to successfully surmount the obstacles faced by innovative biotechnology firms in peripheral countries, which leads in turn to the achievement of technological and financial advantages.
publishDate 2014
dc.date.none.fl_str_mv 2014-03
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/15612
Gutman, Graciela Elena; Lavarello, Pablo Jose; Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges; Inderscience Enterprises Ltd; International Journal Technology and Globalization; 7; 3; 3-2014; 159-178
1476-5667
url http://hdl.handle.net/11336/15612
identifier_str_mv Gutman, Graciela Elena; Lavarello, Pablo Jose; Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges; Inderscience Enterprises Ltd; International Journal Technology and Globalization; 7; 3; 3-2014; 159-178
1476-5667
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://www.inderscienceonline.com/doi/abs/10.1504/IJTG.2014.064740
info:eu-repo/semantics/altIdentifier/doi/10.1504/IJTG.2014.064740
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/zip
application/pdf
dc.publisher.none.fl_str_mv Inderscience Enterprises Ltd
publisher.none.fl_str_mv Inderscience Enterprises Ltd
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846782412299698176
score 13.199325